Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients receiving statins for primary prevention of CVD tend to have lower adherence than in secondary prevention.5”
In the citing paper
“This is reflected in a systematic review where interventions that included reminders and pharmacist support improved adherence outcomes for the purpose of 'intensification of care', 100 more so in chronic patients, 5,12 highlighting effective communication between trained personnel and patients as a key determinant of long-term medication adherence.101”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“All of these calculators include the following components to calculate the risk of CVD; age, gender, smoking status, systolic blood pressure, the level of LDL-C and presence of co-morbid diabetes and hypertension, and some contain additional factors [8].”
BackgroundInfluentialEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
The PICO strategy for the research question construction and evidence search
Santos, C. M. D. C., Pimenta, C. A. D. M., & Nobre, M. R. C. (2007) · Revista Latino-Americana de Enfermagem · doi:10.1590/s0104-11692007000300023 · Cited by 2,342 · cited 1×
“EMbase, Medline, CINAHL (Cumulative Index to Nursing and Allied Health Literature) and PsycInfo databases were searched from January 1984 (when the first trials of statins were published) until May 2017 [27], using Patient Intervention Comparison Outcome (PICO) search methodology to build the following strategy [28]:…”
MethodUpdated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group
van Tulder, M., Furlan, A., Bombardier, C., & Bouter, L. (2003) · Spine · doi:10.1097/01.brs.0000065484.95996.af · Cited by 2,180 · cited 2×
“Predictor data that did not meet criteria for quantitative synthesis, or data where the pooled estimate possessed high heterogeneity (I(2)>50%), were qualitatively compared across studies and evaluated based on the definitions of strong, moderate, limited and conflicting evidence of van Tulder and colleagues [30].”
BackgroundMethodA new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531 · cited 1×
“which state that observational studies should be evaluated on the use of appropriate methods to: 1) select participants, 2) measure exposure and outcome variables, 3) control for confounding, 4) reduce bias and 5) analyse data [29] (S2 Table).”
MethodA meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, S., Hofman, A., Mant, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht295 · Cited by 931
Ray, K. K. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.182 · Cited by 446
Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Mann, D. M., Woodward, M., Muntner, P., Falzon, L., & Kronish, I. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p150 · Cited by 329 · cited 2×
“There was moderate to strong evidence that socioeconomic predictors such as wealth, employment status and level of education associate with statin adherence, and these effects have been observed in systematic reviews that have included primary and secondary prevention cohorts combined [20,21].”
BackgroundResultFinegold, J. A., Manisty, C. H., Goldacre, B., Barron, A. J., & Francis, D. P. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314525531 · Cited by 214
Ofori-Asenso, R., Jakhu, A., Zomer, E., Curtis, A. J., Korhonen, M. J., Nelson, M., Gambhir, M., Tonkin, A., Liew, D., & Zoungas, S. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx169 · Cited by 118
McNaughton, R. J., & Shucksmith, J. (2015) · Journal of Public Health · doi:10.1093/pubmed/fdu066 · Cited by 30 · cited 1×
“Qualitative research with a primary prevention cohort found that reasons for intentional statin non-adherence or discontinuation included perceived side effects and the inflexibility of the healthcare provider to switch statins [19].”
Method
Research works printed but not linked: 43
- J Hippisley-Cox, 2017, Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study, BMJ, 357, j2099, 10.1136/bmj.j2099 · DOI · Paper page
- TJ Wang, 2003, A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community, A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community, 290, 1049
- L Degli Esposti, 2012, Adherence to Statin Treatment and Health Outcomes in an Italian Cohort of Newly Treated Patients: Results From an Administrative Database Analysis, Clin Ther, 34, 190, 10.1016/j.clinthera.2011.12.011 · DOI
- JH Watanabe, 2013, Revisiting the medication possession ratio threshold for adherence in lipid management, Curr Med Res Opin, 29, 175, 10.1185/03007995.2013.766164 · DOI · Paper page
- T Xu, 2017, Statin Adherence and the Risk of Stroke: A Dose-Response Meta-Analysis, CNS Drugs, 31, 263, 10.1007/s40263-017-0420-5 · DOI
- A Dragomir, 2010, Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting, Value Heal, 13, 87, 10.1111/j.1524-4733.2009.00583.x · DOI
- E Aarnio, 2015, Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence—Estimates from the Finnish prescription register, Atherosclerosis, 239, 240, 10.1016/j.atherosclerosis.2014.12.059 · DOI
- S Clifford, 2008, Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework, J Psychosom Res, 64, 41, 10.1016/j.jpsychores.2007.05.004 · DOI · Paper page
- M Lemstra, 2012, Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis, Can J Cardiol, 28, 574, 10.1016/j.cjca.2012.05.007 · DOI · Paper page
- WH Xu, 2016, Relationship between statin adherence and long-term clinical consequences in patients with cardiovascular disease: A systematic review and meta-analysis, Int J Clin Exp Med, 9, 9195
- S Deshpande, 2017, A systematic review to assess adherence and persistence with statins, Curr Med Res Opin, 33, 769, 10.1080/03007995.2017.1281109 · DOI · Paper page
- IM Kronish, 2016, Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults, Circ Cardiovasc Qual Outcomes, 9, 364, 10.1161/CIRCOUTCOMES.115.002418 · DOI
- HF Hope, 2016, Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes, RMDOpen, 2, e000171
- JA Rash, 2016, A systematic review of interventions to improve adherence to statin medication: What do we know about what works?, Prev Med (Baltim), 90, 155, 10.1016/j.ypmed.2016.07.006 · DOI
- A Endo, 2010, A historical perspective on the discovery of statins, Proc Jpn Acad Ser B Phys Biol Sci, 86, 484, 10.2183/pjab.86.484 · DOI · Paper page
- M Al-Foraih, 2017, Factors Affecting Adherence to Statins in Hypercholesterolemic Kuwaiti Patients: A Cross-Sectional Study, Med Princ Pract, 26, 35, 10.1159/000450644 · DOI
- MJ Braamskamp, 2015, Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence, Paediatr Drugs, 17, 159, 10.1007/s40272-014-0116-y · DOI
- TN Harrison, 2013, Primary nonadherence to statin therapy: patients’ perceptions, Am J Manag Care, 19, e133
- E Aarnio, 2016, Socioeconomic Inequalities in Statin Adherence Under Universal Coverage. Does Sex Matter?, Circ Cardiovasc Qual Outcomes, 9, 704, 10.1161/CIRCOUTCOMES.116.002728 · DOI
- HA Batal, 2007, Impact of prescription size on statin adherence and cholesterol levels, BMC Heal Serv Res, 7, 175, 10.1186/1472-6963-7-175 · DOI
- CL Bryson, 2008, Alcohol screening scores and medication nonadherence, Ann Intern Med, 149, 795, 10.7326/0003-4819-149-11-200812020-00004 · DOI · Paper page
- G Corrao, 2010, Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy, Clin Ther, 32, 300, 10.1016/j.clinthera.2010.02.004 · DOI
- H Halava, 2015, Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base, PLoS One, 10, e0130901, 10.1371/journal.pone.0130901 · DOI
- P Lavikainen, 2016, Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence, BMJ Open, 6, e011306, 10.1136/bmjopen-2016-011306 · DOI
- S Perreault, 2009, Impact of better adherence to statin agents in the primary prevention of coronary artery disease, Eur J Clin Pharmacol, 65, 1013, 10.1007/s00228-009-0673-0 · DOI
- S Perreault, 2009, Effect of statin adherence on cerebrovascular disease in primary prevention, Am J Med, 122, 647, 10.1016/j.amjmed.2009.01.032 · DOI
- DA Rublee, 2012, Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy, Am J Ther, 19, 24, 10.1097/MJT.0b013e3181ee707e · DOI · Paper page
- JF Slejko, 2014, Adherence to statins in primary prevention: yearly adherence changes and outcomes, J Manag Care Pharm, 20, 51, 10.18553/jmcp.2014.20.1.51 · DOI · Paper page
- H Wallach-Kildemoes, 2013, Adherence to preventive statin therapy according to socioeconomic position, Eur J Clin Pharmacol, 69, 1553, 10.1007/s00228-013-1488-6 · DOI
- S Farsaei, 2015, Adherence to statin therapy in patients with type 2 diabetes: An important dilemma, J Res Med Sci, 20, 109
- H Halava, 2014, Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities, CMAJ, 186, E449, 10.1503/cmaj.131807 · DOI
- DM Mann, 2007, Predictors of Adherence to Statins for Primary Prevention, Cardiovasc Drugs Ther, 21, 311, 10.1007/s10557-007-6040-4 · DOI
- RM Guthrie, 2001, The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program, Clin Ther, 23, 970, 10.1016/S0149-2918(01)80084-9 · DOI
- CS Stilley, 2004, Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment, Ann Behav Med, 27, 117, 10.1207/s15324796abm2702_6 · DOI · Paper page
- M Von Korff, 1992, A chronic disease score from automated pharmacy data, J Clin Epidemiol, 45, 197, 10.1016/0895-4356(92)90016-G · DOI · Paper page
- M Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg & Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- R Horne, 1999, Patients’ beliefs about treatment: the hidden determinant of treatment outcome?, J Psychosom Res, 47, 491, 10.1016/S0022-3999(99)00058-6 · DOI · Paper page
- L Casebeer, 2009, Improving the physician-patient cardiovascular risk dialogue to improve statin adherence, BMC Fam Pract, 10, 48, 10.1186/1471-2296-10-48 · DOI · Paper page
- M Kooy, 2013, Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial, Front Pharmacol, 4
- YJ Chee, 2014, Understanding patients’ perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review, Singapore Med J, 55, 416, 10.11622/smedj.2014099 · DOI · Paper page
- NK Kalia, 2006, Visualizing coronary calcium is associated with improvements in adherence to statin therapy, Atherosclerosis, 185, 394, 10.1016/j.atherosclerosis.2005.06.018 · DOI · Paper page
- PP Reese, 2016, Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes, J Gen Intern Med, 31, 402, 10.1007/s11606-015-3540-y · DOI
- AN de Cates, 2014, Fixed-dose combination therapy for the prevention of cardiovascular disease, Cochrane database Syst Rev, 4, CD009868
Cited by
Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD
Taub, P. R., Gutierrez, A., Wewers, D., Garcia Cantu, E., Cao, H., Deck, C., Lesogor, A., Ott, D., Mena-Madrazo, J., Zang, X., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.04.049 · Cited by 25
Marquina, C., Talic, S., Zomer, E., Vargas-Torres, S., Petrova, M., Wolfe, R., Abushanab, D., Lybrand, S., Thomson, D., Stratton, G., et al. (2022) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2022.05.002 · Cited by 9
Rakhshanda, S., Briggs, N. E., Rhee, J., Rye, K.-A., Liaw, S.-T., & Jonnagaddala, J. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag175 · Cited by 6
Metadata
- Authors
- Hope, H. F., Binkley, G. M., Fenton, S., Kitas, G. D., Verstappen, S. M. M., & Symmons, D. P. M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-01-17
- Volume
- 14
- Issue
- 1
- Pages
- e0201196
- ISSN
- 1932-6203
- Cited by
- 114
- References
- 17
- Language
- en
- Funders
- Arthritis Research UK (16514)
- British Heart Foundation (16514)
- Pfizer UK (16514)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.